Clinical Trials Logo

Healthy Male Volunteers clinical trials

View clinical trials related to Healthy Male Volunteers.

Filter by:
  • Terminated  
  • Page 1

NCT ID: NCT03863587 Terminated - Clinical trials for Healthy Male Volunteers

Compare Pharmacokinetic, Safety, Tolerability and Immunogenicity of HLX12 and Ramucirumab in Healthy Male Adult Subjects

Start date: June 6, 2019
Phase: Phase 1
Study type: Interventional

The study consists of 2 parts: Part I study: to preliminarily compare the PK profile of HLX12 and Cyramza This study is an open-label, randomized, parallel-controlled, intravenous single-dose pretrial study comparing the pharmacokinetic profile, safety, tolerability and immunogenicity of HLX12 and Ramucirumab in healthy male adult subjects. The number of subjects is set to 24, who will be randomized into two groups, and each group has the same number of subjects (n=12). Group 1 will receive intravenous infusion of the test preparation T HLX12, while Group 2 will receive Cyramza, once in both groups. Part II study: to compare the PK similarity between HLX12 and Cyramza This study is a randomized, double-blind, parallel-controlled, intravenous single-dose Phase I clinical study comparing the pharmacokinetic profile, safety, tolerability and immunogenicity of HLX12 and Ramucirumab in healthy male adult subjects.The number of subjects is set to 128, and the treatment is the same with Part I study.

NCT ID: NCT01965301 Terminated - Clinical trials for Healthy Male Volunteers

First-time-in-man, to Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of BP1.5375

Start date: October 2014
Phase: Phase 1
Study type: Interventional

Phase I Single Ascending Dose (Part 1), phase IIa Proof Of Concept (Part 2)